Clinical efficacy of avatrombopag and recombinant human thrombopoietin in the treatment of chronic liver disease-associated severe thrombocytopenia: A real-world study

Purpose: To investigate the clinical efficacy of avatrombopag, an oral thrombopoietin receptor agonist, versus subcutaneous recombinant human thrombopoietin (rh-TPO) in the treatment of severe thrombocytopenia (TCP) associated with chronic liver disease (CLD). Methods: Clinical data of 250 patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yong-Shuai, Wang, Wei, Zhang, Sai, Zhang, Shen-Yu, Shen, Ai-Zong, Song, Hua-Chuan, Yao, Huan-Zhang, Song, Rui-Peng, Meng, Fan-Zheng, Li, Lei, Nashan, Bjoern, Wang, Ji-Zhou, Liu, Lian-Xin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9577549/
https://www.ncbi.nlm.nih.gov/pubmed/36267268
http://dx.doi.org/10.3389/fphar.2022.1009612

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9577549/
https://www.ncbi.nlm.nih.gov/pubmed/36267268
http://dx.doi.org/10.3389/fphar.2022.1009612

Ejemplares similares